The company aims to replace traditional surgery for bladder tumor removal with a simpler in-office procedure that could lower costs, shorten recovery time, and reduce risks for patients.

Israeli researchers have used brainwaves of humans under strain to control the release of medicine by tiny robots made from shells made of DNA; Israeli-based NRGene is turning its attention to the human genome in order to help diagnose genetic disorders at an early stage, and much more.